Additionally, BGN4 lowered plasma low-density lipoprotein, alanine aminotransferase, and aspartate aminotransferase levels, indicating its potential to alleviate renal IRI and AKI-related liver damage (29). The gene discussed is GPT; the disease is acute kidney injury.